| Application no. and date | 15736015.7 (espacenet) (Federated) (European Patent Register), 20150626 | | Patent/reg. no. and date | DK/EP 3160948, 20181024 | | Publication date | 20170503 | | Priority no. and date | US 201462018790 P, 20140630 | | EP pub. no. and date |
EP 3160948 20170503 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | AST 200204-EP-EPT | | Inventor | CORNWALL, Philip, AstraZeneca
Charter Way
Macclesfield
Cheshire SK10 2NA, GB,
Edman, Karl, AstraZeneca R&D Mölndal
SE-431 83 Mölndal, SE,
O'MAHONY, Gavin, AstraZeneca
R&D Mölndal
SE-431 83 Mölndal, SE,
KOSSENJANS, Michael, AstraZeneca
R&D Mölndal
SE-431 83 Mölndal, SE,
KAJANUS, Johan, AstraZeneca
R&D Mölndal
SE-431 83 Mölndal, SE,
HOGNER, Carl Anders, AstraZeneca
R&D Mölndal
SE-431 83 Mölndal, SE,
TURNER, Andrew, AstraZeneca
Charter Way
Macclesfield
Cheshire SK10 2NA, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/538 (2006.01) , A61P 9/12 (2006.01) , C07D 265/36 (2006.01) | | Title | BENZOXAZINONAMIDER SOM MODULATORER AF MINERALOCORTICOIDRECEPTORER | | Int. application no. | GB2015051860 | | Int. publication no. | WO2016001631 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
